Employing an in-vitro cell culture model, Lundburg et al. substantiated that Sox2-expressing cells exhibit CSC-like features, which is concomitant with a reduced level of CDX2, a state typically observed in late-stage CRC patients (Lugli et al., 2010). The gene discussed is SOX2; the disease is colorectal carcinoma.